Quantitative MRI and strength measurements in the assessment of muscle quality in Duchenne muscular dystrophy

The purpose of this study was to assess leg muscle quality and give a detailed description of leg muscle involvement in a series of Duchenne muscular dystrophy patients using quantitative MRI and strength measurements. Fatty infiltration, as well as total and contractile (not fatty infiltrated) cross sectional areas of various leg muscles were determined in 16 Duchenne patients and 11 controls (aged 8-15). To determine specific muscle strength, four leg muscle groups (quadriceps femoris, hamstrings, anterior tibialis and triceps surae) were measured and related to the amount of contractile tissue. In patients, the quadriceps femoris showed decreased total and contractile cross sectional area, attributable to muscle atrophy. The total, but not the contractile, cross sectional area of the triceps surae was increased in patients, corresponding to hypertrophy. Specific strength decreased in all four muscle groups of Duchenne patients, indicating reduced muscle quality. This suggests that muscle hypertrophy and fatty infiltration are two distinct pathological processes, differing between muscle groups. Additionally, the quality of remaining muscle fibers is severely reduced in the legs of Duchenne patients. The combination of quantitative MRI and quantitative muscle testing could be a valuable outcome parameter in longitudinal studies and in the follow-up of therapeutic effects.

[1]  P. Wollan,et al.  Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy. , 1996, Pediatric neurology.

[2]  Francesco Muntoni,et al.  Muscle imaging in clinical practice: diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders , 2005, Current opinion in neurology.

[3]  Bernard J. Dardzinski,et al.  T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. , 2010, Radiology.

[4]  Arend Heerschap,et al.  Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy , 2009, Neuromuscular Disorders.

[5]  J. Morley,et al.  Branched fibers in dystrophic mdx muscle are associated with a loss of force following lengthening contractions. , 2007, American journal of physiology. Cell physiology.

[6]  G. van Ommen,et al.  Systemic administration of PRO051 in Duchenne's muscular dystrophy. , 2011, The New England journal of medicine.

[7]  C. Senesac,et al.  Relationships of thigh muscle contractile and non-contractile tissue with function, strength, and age in boys with Duchenne muscular dystrophy , 2012, Neuromuscular Disorders.

[8]  S. Reeder,et al.  Multiecho water‐fat separation and simultaneous R  2* estimation with multifrequency fat spectrum modeling , 2008, Magnetic resonance in medicine.

[9]  H. Sweeney,et al.  Dystrophin protects the sarcolemma from stresses developed during muscle contraction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Leroy-Willig.  Quantitative MR evaluation of body composition in patients with Duchenne muscular dystrophy , 2002, European Radiology.

[11]  S. Reeder,et al.  Multiecho reconstruction for simultaneous water‐fat decomposition and T2* estimation , 2007, Journal of magnetic resonance imaging : JMRI.

[12]  J. Mendell,et al.  Gentamicin‐induced readthrough of stop codons in duchenne muscular dystrophy , 2010, Annals of neurology.

[13]  Claude Desnuelle,et al.  Development of a French isometric strength normative database for adults using quantitative muscle testing. , 2007, Archives of physical medicine and rehabilitation.

[14]  K. Bushby,et al.  Magnetic resonance imaging in duchenne muscular dystrophy: Longitudinal assessment of natural history over 18 months , 2013, Muscle & nerve.

[15]  E. Mercuri,et al.  Muscle histology vs MRI in Duchenne muscular dystrophy , 2011, Neurology.

[16]  W. T. Dixon.  Simple proton spectroscopic imaging. , 1984, Radiology.

[17]  B. Tseng,et al.  Lower leg muscle involvement in Duchenne muscular dystrophy: an MR imaging and spectroscopy study , 2012, Skeletal Radiology.

[18]  A. Connolly,et al.  Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging , 2005, Skeletal Radiology.

[19]  G. Serratrice,et al.  Muscle hypertrophy in Duchenne muscular dystrophy , 2004, Journal of Neurology.

[20]  W. Triplett,et al.  T2 mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross‐sectional study of lower leg muscles in 5–15‐year‐old boys with Duchenne muscular dystrophy , 2013, NMR in biomedicine.

[21]  F. Muntoni,et al.  Restoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophy. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  Vicente Gilsanz,et al.  Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. , 2008, AJR. American journal of roentgenology.

[23]  M. Reijnierse,et al.  Comparison of dixon and T1‐weighted MR methods to assess the degree of fat infiltration in duchenne muscular dystrophy patients , 2013, Journal of magnetic resonance imaging : JMRI.

[24]  Benjamin S. Aribisala,et al.  MR imaging in Duchenne muscular dystrophy: Quantification of T1‐weighted signal, contrast uptake, and the effects of exercise , 2009, Journal of magnetic resonance imaging : JMRI.

[25]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[26]  N. Curtin,et al.  THE mdx MOUSE SKELETAL MUSCLE MYOPATHY: II. CONTRACTILE PROPERTIES , 1988, Neuropathology and applied neurobiology.

[27]  G. Liu,et al.  Duchenne muscular dystrophy: MR grading system with functional correlation. , 1993, Radiology.

[28]  Krista Vandenborne,et al.  Chemical shift‐based MRI to measure fat fractions in dystrophic skeletal muscle , 2014, Magnetic resonance in medicine.

[29]  O. Bieri,et al.  Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy , 2013, Journal of Neurology.

[30]  J. Grieger,et al.  Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[31]  Vicente Gilsanz,et al.  Fat quantification using three-point dixon technique: in vitro validation. , 2005, Academic radiology.

[32]  V. Dubowitz,et al.  Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy , 1990, Journal of the Neurological Sciences.

[33]  Krista Vandenborne,et al.  Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy. , 2010, Archives of physical medicine and rehabilitation.

[34]  M. Gaeta,et al.  Muscle fat fraction in neuromuscular disorders: dual-echo dual-flip-angle spoiled gradient-recalled MR imaging technique for quantification--a feasibility study. , 2011, Radiology.

[35]  R. Finkel,et al.  Skeletal muscles of ambulant children with Duchenne muscular dystrophy: validation of multicenter study of evaluation with MR imaging and MR spectroscopy. , 2013, Radiology.